Anteo Diagnostics Ltd (ADO):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Anteo Diagnostics Ltd (ADO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C11407
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Anteo Diagnostics Ltd (Anteo Diagnostics) is a leading medical technology company that develops and commercializes healthcare products. The company along with its subsidiaries provides immunoassays, in-vitro diagnostics, and point of care (PoC) tests to life sciences, bio-separation, clinical diagnostic, and medical device markets, including a PoC test for the diagnosis of heart attacks (troponin test). It holds patents for nanometre-thin primers, binders, and coatings. Anteo Diagnostics’s patented nanoglue technology, Mix&Go, finds application in healthcare industry. The company is also investigating its nanoglue technology for attaching bio-molecules to synthetic surfaces and evaluating its potential in the manufacture of batteries. It has subsidiaries in Australia, Belgium and Spain. Anteo Diagnostics is headquartered in Brisbane, Queensland, Australia.

Anteo Diagnostics Ltd (ADO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Anteo Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Anteo Diagnostics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Anteo Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Anteo Diagnostics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Anteo Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Anteo Diagnostics Ltd, Medical Equipment, Deal Details 11
Private Equity 11
Bergen Global Opportunity Fund Invests USD1.5 Million in Anteo Diagnostics 11
Partnerships 12
Anteo Diagnostics Enters Into Licensing Agreement With eBioscience For Mix&Go Technology 12
Anteo Diagnostics Partners with Atomo Diagnostics 13
Anteo Diagnostics Enters Into Distribution Agreement With Gennova Scientific For Mix&Go 14
Equity Offering 15
Anteo Diagnostics Raises USD1 Million in Third Tranche of Private Placement of Shares 15
Anteo Diagnostics to Raise USD8.6 Million in Rights Offering of Shares 16
Anteo Diagnostics Completes Private Placement Of Shares For US$5 Million 17
Debt Offering 18
Anteo Diagnostics to Raise USD10.6 Million in Private Placement of 10% Notes 18
Acquisition 19
Anteo Diagnostics Sells DIAsource to BioVendor for USD19 Million 19
Anteo Diagnostics Completes Acquisition of DIAsource for USD16.7 Million 20
Anteo Diagnostics Ltd – Key Competitors 21
Anteo Diagnostics Ltd – Key Employees 22
Anteo Diagnostics Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Aug 31, 2018: Anteo Diagnostics: 30 June 2018 unaudited preliminary financial statements 24
Sep 01, 2017: Anteo Diagnostics: 30 June 2017 Preliminary Financial Statements 25
Apr 28, 2017: Anteo Diagnostics: Quarterly Activities Report 26
Corporate Communications 29
Sep 10, 2018: Anteo Diagnostics: Appointment of chief executive officer 29
Apr 09, 2018: Anteo Diagnostics: CEO Resignation and CEO Appointment 30
Apr 03, 2018: Anteo Diagnostics: Chairman Appointed and Board Changes 31
Dec 06, 2017: Anteo Diagnostics: Appointment of Chief Executive Officer 32
Sep 01, 2017: Management changes resulting from sale of DIAsource 33
Product News 34
Jan 12, 2017: Anteo Diagnostics Strengthening its Intellectual Property Position in Medical Device Arena 34
Other Significant Developments 35
Jul 30, 2018: Anteo Diagnostics: Activities report – Quarter ended 30 June 2018 35
Apr 27, 2018: Anteo Diagnostics: Activities Report – Quarter Ended 31 March 2018 38
Jan 31, 2018: Activities Report – Quarter Ended 31 December 2017 40
Oct 31, 2017: Anteo Diagnostics: Activities Report – Quarter Ended 30 September 2017 42
Jan 31, 2017: Anteo Diagnostics: Quarter Ended 31 December 2016 45
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
Anteo Diagnostics Ltd, Medical Equipment, Key Facts, 2018 2
Anteo Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Anteo Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Anteo Diagnostics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Anteo Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Anteo Diagnostics Ltd, Deals By Market, 2012 to YTD 2018 9
Anteo Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Bergen Global Opportunity Fund Invests USD1.5 Million in Anteo Diagnostics 11
Anteo Diagnostics Enters Into Licensing Agreement With eBioscience For Mix&Go Technology 12
Anteo Diagnostics Partners with Atomo Diagnostics 13
Anteo Diagnostics Enters Into Distribution Agreement With Gennova Scientific For Mix&Go 14
Anteo Diagnostics Raises USD1 Million in Third Tranche of Private Placement of Shares 15
Anteo Diagnostics to Raise USD8.6 Million in Rights Offering of Shares 16
Anteo Diagnostics Completes Private Placement Of Shares For US$5 Million 17
Anteo Diagnostics to Raise USD10.6 Million in Private Placement of 10% Notes 18
Anteo Diagnostics Sells DIAsource to BioVendor for USD19 Million 19
Anteo Diagnostics Completes Acquisition of DIAsource for USD16.7 Million 20
Anteo Diagnostics Ltd, Key Competitors 21
Anteo Diagnostics Ltd, Key Employees 22
Anteo Diagnostics Ltd, Subsidiaries 23

List of Figures
Anteo Diagnostics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Anteo Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Anteo Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Anteo Diagnostics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Anteo Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Anteo Diagnostics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Anteo Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Anteo Diagnostics Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Anteo Diagnostics Ltd (ADO):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ann Inc:企業の戦略的SWOT分析
    Ann Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Compania Espanola de Petroleos SAU-エネルギー分野:企業M&A・提携分析
    Summary Compania Espanola de Petroleos, S.A.U. (CEPSA) is an integrated energy company. It explores, produces, refines, transports and markets crude oil, petroleum products, and natural gas. It also produces and distributes electricity; manufactures, distributes, and sells basic petrochemicals, petr …
  • CellSeed Inc (7776):製薬・医療:M&Aディール及び事業提携情報
    Summary CellSeed Inc (CellSeed) is a developer of regenerative medicine. The company’s products include epithelial cell sheet for corneal regeneration, regenerated cardiac patch, epithelial cell sheet for esophageal regeneration, cell sheet for periodontal tissue regeneration and regenerated cartila …
  • Bruel & Kjaer Sound & Vibration Measurement AS:企業の戦略・SWOT・財務情報
    Bruel & Kjaer Sound & Vibration Measurement AS - Strategy, SWOT and Corporate Finance Report Summary Bruel & Kjaer Sound & Vibration Measurement AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Radico Khaitan Ltd.:企業の戦略・SWOT・財務情報
    Radico Khaitan Ltd. - Strategy, SWOT and Corporate Finance Report Summary Radico Khaitan Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • TXU Energy Retail Company LLC:企業の戦略的SWOT分析
    TXU Energy Retail Company LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Mercuria Energy Group Ltd:企業のM&A・事業提携・投資動向
    Mercuria Energy Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mercuria Energy Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • RayBiotech Inc:医療機器:M&Aディール及び事業提携情報
    Summary RayBiotech Inc (RayBiotech) is a life science company that provides proteins, antibodies and immunological kits. The company's product categories include antibody arrays, glycobiology arrays, protein arrays, phosphorylation arrays, elisa, functional assays, antibodies and custom recombinant …
  • iHeartMedia, Inc.:戦略・SWOT・企業財務分析
    iHeartMedia, Inc. - Strategy, SWOT and Corporate Finance Report Summary iHeartMedia, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ogeda SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Ogeda SA (Ogeda), formerly Euroscreen SA, a subsidiary of Astellas Pharma Inc, is a clinical-stage drug discovery company that invents and develops fezolinetant and small molecule drugs targeting G-protein coupled receptors. The company discovers and develops drugs that treat hormone-depende …
  • Romelectro S.A.:企業の戦略的SWOT分析
    Romelectro S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • PsychoGenics Inc-製薬・医療分野:企業M&A・提携分析
    Summary PsychoGenics Inc (PsychoGenics) is an preclinical contract research organization that offers contract research, standard and customized preclinical services and drug discovery services. The organization offers various behavioral tests to drug candidates in the areas of pain and inflammation, …
  • Agfa-Gevaert N.V.:企業の戦略・SWOT・財務情報
    Agfa-Gevaert N.V. - Strategy, SWOT and Corporate Finance Report Summary Agfa-Gevaert N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • National Fertilizers Ltd (NFL):企業の財務・戦略的SWOT分析
    Summary National Fertilizers Ltd (NFL) is a chemical company that develops, manufactures and markets urea, bio-fertilizers and other industrial products. The company’s bio-fertilizers comprise phosphorous bio-fertilizers and nitrogenbio-fertilizers. Its industrial products include ammonium nitrate, …
  • KB Securities Vietnam Joint Stock Company:企業の戦略的SWOT分析
    KB Securities Vietnam Joint Stock Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • ULURU Inc (ULUR):医療機器:M&Aディール及び事業提携情報
    Summary ULURU Inc (ULURU) is a medical technology company that researches, develops, and markets wound care and muco-adhesive film products. The company’s products include Altrazeal and OraDisc. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of exuding wo …
  • Georgia Power Co:企業の戦略的SWOT分析
    Georgia Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Vocalink Limited
    Vocalink Limited - Strategy, SWOT and Corporate Finance Report Summary Vocalink Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • HedgePath Pharmaceuticals Inc (HPPI):製薬・医療:M&Aディール及び事業提携情報
    Summary Hedgepath Pharmaceuticals Inc (Hedgepath), a subsidiary of Mayne Pharma Group Ltd, is a clinical stage biopharmaceutical company that discovers, develops and commercializes novel therapeutics for the treatment of skin, prostrate, and lung cancers. The company is investigating an oral formula …
  • Kore Potash Plc (ELM):企業の財務・戦略的SWOT分析
    Summary Kore Potash Plc (Kore Potash), formerly Elemental Minerals Ltd, is a mining company that offers exploration and development of mineral resources. The company offers development of potash project in the Republic of Congo and operates an exploration project in Australia. It also owns and opera …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆